Stay updated on Ibrutinib Combo in Recurrent HNSCC Clinical Trial

Sign up to get notified when there's something new on the Ibrutinib Combo in Recurrent HNSCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ibrutinib Combo in Recurrent HNSCC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Status indicators were updated to show 'Results Submitted' and 'Revision: v3.4.3'. The previous 'No Results Posted' and 'Revision: v3.4.2' indicators were removed.
    Difference
    0.1%
    Check dated 2026-03-11T17:29:15.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed the previous operating-status notice (Revision: v3.4.1) from the page.
    Difference
    0.4%
    Check dated 2026-02-11T04:49:19.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A site-wide notice about government funding and a version update from v3.4.0 to v3.4.1 appear on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T03:27:53.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Show glossary is now enabled on the page, and the label for the updated QC metric has been changed to 'Last Update Submitted that Met QC Criteria'. The footer now includes 'No FEAR Act Data' and the page revision shows 'Revision: v3.4.0'.
    Difference
    0.2%
    Check dated 2026-01-28T00:27:51.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision: v3.3.4 replaces v3.3.3 on the page, indicating a small metadata update with no substantive changes to the study information.
    Difference
    0.1%
    Check dated 2026-01-14T01:17:53.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Added a Locations section with California and updated the revision to v3.3.3; removed California Locations and HHS Vulnerability Disclosure.
    Difference
    0.2%
    Check dated 2025-12-23T09:17:22.000Z thumbnail image

Stay in the know with updates to Ibrutinib Combo in Recurrent HNSCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ibrutinib Combo in Recurrent HNSCC Clinical Trial page.